Help | RSS Feed



Enzon, Inc. (OTCMKT:ENZN) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Enzon, Inc. (OTCMKT:ENZN) seasonal charts above shows that a Buy Date of May 22 and a Sell Date of August 13 has resulted in a geometric average return of 4.28% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 23.14% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Enzon Pharmaceuticals Inc is a pharmaceutical company. Its four licensed products comprise of PegIntron, and Sylatron. PegIntron is used both as a monotherapy and in combination with REBETOL (ribavirin) capsules for the treatment of chronic hepatitis C. Sylatron is used for the treatment of melanoma. The company earns revenue in the form of royalties.

To download ENZN seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z